These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


147 related items for PubMed ID: 25732979

  • 1. CT-1 induces angiogenesis by regulating the ADMA/DDAH Pathway.
    Zheng ZZ, Tian Fu X, Liang J, Bing Guo Z.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Dec; 159(4):540-6. PubMed ID: 25732979
    [Abstract] [Full Text] [Related]

  • 2. The ADMA/DDAH pathway regulates VEGF-mediated angiogenesis.
    Fiedler LR, Bachetti T, Leiper J, Zachary I, Chen L, Renné T, Wojciak-Stothard B.
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2117-24. PubMed ID: 19778944
    [Abstract] [Full Text] [Related]

  • 3. Protection of DDAH2 overexpression against homocysteine-induced impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells.
    Liu LH, Guo Z, Feng M, Wu ZZ, He ZM, Xiong Y.
    Cell Physiol Biochem; 2012 Dec; 30(6):1413-22. PubMed ID: 23171931
    [Abstract] [Full Text] [Related]

  • 4. Nitric oxide upregulates dimethylarginine dimethylaminohydrolase-2 via cyclic GMP induction in endothelial cells.
    Sakurada M, Shichiri M, Imamura M, Azuma H, Hirata Y.
    Hypertension; 2008 Nov; 52(5):903-9. PubMed ID: 18824664
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. CD151 gene delivery increases eNOS activity and induces ECV304 migration, proliferation and tube formation.
    Zheng ZZ, Liu ZX.
    Acta Pharmacol Sin; 2007 Jan; 28(1):66-72. PubMed ID: 17184584
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dimethylarginine dimethylaminohydrolase activity modulates ADMA levels, VEGF expression, and cell phenotype.
    Smith CL, Birdsey GM, Anthony S, Arrigoni FI, Leiper JM, Vallance P.
    Biochem Biophys Res Commun; 2003 Sep 05; 308(4):984-9. PubMed ID: 12927816
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Quercetin protects the vascular endothelium against iron overload damages via ROS/ADMA/DDAHⅡ/eNOS/NO pathway.
    Chen X, Li H, Wang Z, Zhou Q, Chen S, Yang B, Yin D, He H, He M.
    Eur J Pharmacol; 2020 Feb 05; 868():172885. PubMed ID: 31870832
    [Abstract] [Full Text] [Related]

  • 12. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
    Trocha M, Merwid-Ląd A, Chlebda-Sieragowska E, Szuba A, Pieśniewska M, Fereniec-Gołębiewska L, Kwiatkowska J, Szeląg A, Sozański T.
    Exp Gerontol; 2014 Feb 05; 50():45-51. PubMed ID: 24269305
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. all-trans-Retinoic acid increases nitric oxide synthesis by endothelial cells: a role for the induction of dimethylarginine dimethylaminohydrolase.
    Achan V, Tran CT, Arrigoni F, Whitley GS, Leiper JM, Vallance P.
    Circ Res; 2002 Apr 19; 90(7):764-9. PubMed ID: 11964368
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Involvement of the endothelial DDAH/ADMA pathway in nitroglycerin tolerance: the role of ALDH-2.
    Zhang GG, Shi RZ, Jiang DJ, Chen YR, Jia-Chen, Tang ZY, Bai YP, Xiao HB, Li YJ.
    Life Sci; 2008 Mar 26; 82(13-14):699-707. PubMed ID: 18289604
    [Abstract] [Full Text] [Related]

  • 18. Taurine protects against low-density lipoprotein-induced endothelial dysfunction by the DDAH/ADMA pathway.
    Tan B, Jiang DJ, Huang H, Jia SJ, Jiang JL, Hu CP, Li YJ.
    Vascul Pharmacol; 2007 May 26; 46(5):338-45. PubMed ID: 17293168
    [Abstract] [Full Text] [Related]

  • 19. Estradiol, acting through estrogen receptor alpha, restores dimethylarginine dimethylaminohydrolase activity and nitric oxide production in oxLDL-treated human arterial endothelial cells.
    Novella S, Laguna-Fernández A, Lázaro-Franco M, Sobrino A, Bueno-Betí C, Tarín JJ, Monsalve E, Sanchís J, Hermenegildo C.
    Mol Cell Endocrinol; 2013 Jan 05; 365(1):11-6. PubMed ID: 22982060
    [Abstract] [Full Text] [Related]

  • 20. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
    Selley ML.
    J Affect Disord; 2004 Jun 05; 80(2-3):249-56. PubMed ID: 15207938
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.